SCHEMBL14714

SCHEMBL14714

CCOC(=O)C(=O)C1CSc2ccc(OC)cc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.41
RYR2 Q92736 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 3/20 0.38
GAA P10253 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
BRD4 O60885 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ACHE P22303 1/20 0.36
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30308389 0.91 KDM4E (0.43) PPARGL3MBTL1ALDH1A1KDM4EMAPT
SCHEMBL24188767 0.91 KDM4E (0.43) PPARGL3MBTL1ALDH1A1KDM4EMAPT
SCHEMBL9534884 0.88 RYR2 (0.44) RYR2ALDH1A1KDM4EMAPTHPGD
SCHEMBL4728124 0.85 KDM4E (0.45) L3MBTL1ALDH1A1KDM4EMAPTGAA
SCHEMBL13214 0.85 KDM4E (0.44) ALDH1A1KDM4EMAPTGAAHSD17B10
SCHEMBL12276706 0.84 RYR2 (0.45) RYR2ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL9522559 0.84 KDM4E (0.44) ALDH1A1KDM4EMAPTGAAHSD17B10
SCHEMBL30460538 0.82 ALDH1A1 (0.41) L3MBTL1ALDH1A1KDM4EMAPTGAA
SCHEMBL7554 0.82 ALDH1A1 (0.41) L3MBTL1ALDH1A1KDM4EMAPTGAA
SCHEMBL30308393 0.81 KDM4E (0.41) L3MBTL1ALDH1A1KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
WO-2011058149-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO S.A. (CH) 2011-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES PI4KB, MTOR, PI4KA PPARG 830/4885RYR2 4407/4885L3MBTL1 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.